Since inception, IVI has championed a focus on patient-centered outcomes and preferences as drivers of change, emphasized modern thinking about methods and value elements that should be included in value assessment models, and advocated for transparent, open-source model development to improve dialogue and build trust between users, decision-makers, and patient communities.

IVI is governed by our Board of Directors, with input from our Scientific Advisory Panel and our Patient Advisory Council. All Board members are required to disclose any potential conflicts of interest, and must recuse themselves from any decision involving a potential conflict. For a copy of our Conflict of Interest Policy, Nonprofit Determination Letter, Bylaws or 990, please contact [email protected].

Learn more about our principles for value assessment in the US or visit our visit our FAQ section for additional information.

The Innovation and Value Initiative (IVI) is led by nationally recognized scientists, with forward-thinking practitioners representing the payer community, life sciences firms, integrated delivery systems, health care providers, and patient advocates. This group includes health care experts that have pioneered new methods for measuring and rewarding value, nationally-known thought leaders, and innovators on the frontline of new approaches to health care delivery.

Learn more about the leaders changing the way we think about value: